Haemophilus influenzae (-) , , 6 . - 10-24 %.[ 2234 ]
- 40-100 100 . 1980 . 1,3 100 . 1990 .[10] - 20 % (., 5,0 3,9 1000)[11]. , , - . - , , -. - , . - (- , ѻ ).[ 2234 ]
( 3 , 2 , 4 ), [12]. , 23- 6,54 0,67 1 , , [13], 7 , [14].
23- ( ) 60 % [15].
[16][17], [18] ( 4,6). ( ) 2,4 [19].
( 1 82 %)[20], , , , . , , , [21].
: , , , , , , , , , .
|
|
, , . , , . .
1. ↑ / . . .. . 4- . .: , 1988. 1600 .
2. ↑ McLuckie [editor] A. Respiratory disease and its management. New York: Springer, 2009. P. 51. ISBN 9781848820944.
3. ↑ Leach, Richard E. Acute and Critical Care Medicine at a Glance. 2. Wiley-Blackwell, 2009. ISBN 1-4051-6139-6.
4. ↑ . , . - (31.08.2015).
5. ↑ Stringer JR, Beard CB, Miller RF, Wakefield AE (September 2002). A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerging Infect. Dis. 8 (9): 8916. PMID 12194762.
6. ↑ World Health Organization. Pneumococcal vaccines. Wkly Epidemiol Rec, 2003; 78(14):110-9
7. ↑ . ., . , 11, 2002
8. ↑ Fedson DS, Musher DM. Pneumococcal vaccine. In: Plotkin SA, Orenstein WA, editors. Vaccines. 4th ed. Philadelphia: Saunders; 2004. p. 529-88.
9. ↑
10. ↑ CDC
11. ↑ -2007 ( 8- , ) . . . , . . . : -, 2007, . 95
12. ↑ . ., . ., . . 23 - . 5:9-11, 2003.
13. ↑ . . . . , ., 2002.
14. ↑ . ., . . // . 1995. 2. .914.
15. ↑ - 23 -: . . . ., ., 2004
16. ↑ Nichol KL et al. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease. Arch Intern Med 159:2437-2442, 1999
17. ↑ Alfageme I. Clinical efficacy of anti-pneumococcal vaccination in patients with COPD. Thorax 61: 189195, 2006
18. ↑ . . - : , , 2005
19. ↑ . ., . ., . .. . (- ǻ, ). , 2007, 3
20. ↑ Miller EV, Watt JP, Bronsdon MA, et al. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members. Clin Infect Dis 2008; 47: 989996 [1]
|
|
21. ↑ Musher DM. Pneumococcal vaccinedirect and indirect (herd) effects. N Engl J Med 2006; 354: 15221528.15
// : 86 . (82 . 4 .). ., 18901907.